RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's ...
Postmenopausal women and men over 50 years of age. Clinical data on this first group of patients are very scarce because of difficulties in fracture risk assessment, owing to the lack of reliable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback